Icu Medical (ICUI) EBIT (2009 - 2026)

Icu Medical (ICUI) has reported EBIT for 18 consecutive years, with $39.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBIT rose 269.58% year-over-year to $39.1 million; the trailing twelve-month figure through Jun 2026 stood at $72.1 million (up 3.83% YoY), and the FY2025 full-year result was $42.8 million, changed 0.31% from the prior year.
• EBIT grew to $39.1 million in Q2 2026 per ICUI's latest filing, from $13.6 million in the prior quarter.
• Across five years, EBIT topped out at $39.1 million in Q2 2026 and bottomed at -$42.2 million in Q1 2022.
• Historically, EBIT has averaged $6.6 million across 5 years, with a median of $8.0 million in 2024.
• The widest YoY moves for EBIT: up 5850.0% in 2023, down 5387.84% in 2023.
• Over 5 years, EBIT stood at -$222000.0 in 2022, then plunged by 5387.84% to -$12.2 million in 2023, then jumped by 409.37% to $37.7 million in 2024, then tumbled by 85.05% to $5.6 million in 2025, then jumped by 594.36% to $39.1 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered $39.1 million, $13.6 million, and $5.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.